User menu

Accès à distance ? S'identifier sur le proxy UCLouvain | Saint-Louis

Search

Displaying 8 results.
    • Journal article
    Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
    Neyns, Bart Baurain, Jean-François[UCL] Sadones, J. Joosens, E. Bouttens, F. Verbeke, L. D'Hondt, Lionel[UCL] Strauven, T. Chaskis, C. In't Veld, P. Michotte, A. De Greve, J. (2009) Annals of Oncology — Vol. 20, no. 9, p. 1596-603 (2009)
    • Journal article
    High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer: a randomised phase II-III trial of the EORTC Gastrointestinal Group
    Wils, J. Blijham, GH Wagener, T De Greve, J. Jansen, RLH Kok, TC Nortier, JWR Bleiberg, H. Couvreur, ML Genicot, B Baron, B (2003) European Journal of Cancer — Vol. 39, no. 3, p. 346-352 (2003)
    • Journal article
    Gefitinib monotherapy in advanced nonsmall cell lung cancer: a large Western community implementation study
    van Puijenbroek, R. Collard, Philippe[UCL] Bosquée, L.[UCL] Meert, A-P. Schallier, D. Goeminne, J-C. Tits, G. Nackaerts, Kristiaan[UCL] Canon, J-L. Duplaquet, Fabrice Galdermans, D. Germonpre, P. Azerad, M-A. Vandenhoven, G. De Greve, J. Vansteenkiste, J. (2007) The European Respiratory Journal — Vol. 29, no. 1, p. 128-33 (2007)
    • Journal article
    Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study.
    D'hondt, Véronique[UCL] Humblet, Yves[UCL] Guillaume, T. Baatout, S. Chatelain, Christian[UCL] Berlière, M[UCL] Longueville, Jacques[UCL] Feyens, Anne Marie[UCL] De Greve, J. Van Oosterom, A. (1995) Blood — Vol. 85, no. 9, p. 2347-53 (1995)
    • Speech
    Gefitinib monotherapy in advanced non-small cell lung cancer (NSCLC): Experience from a large, Western community implementation study
    van Puijenbroek, R. Collard, Philippe[UCL] Bosquée, L.[UCL] Meert, A. P. Schallier, D. Goeminne, J-C. Tits, G. Nackaerts, Kristiaan[UCL] Canon, J-L. Duplaquet, Fabrice Galdermans, D. Germonpre, P. Azerad, M. -A. Vandenhoven, G. De Greve, J. Vansteenkiste, J. (2006) 10th Central European Lung Cancer Conference — Prague (Czech Republic)
    • Speech
    Activity of sunitinib in advanced malignant melanoma and its correlation with potential predictive biomarkers
    Decoster, L. Neyn, B. Vande Broek, I. Anckaert, E. De Clerck, D. De Mey, J. Majois, F.[UCL] Baurain, Jean-François[UCL] Denys, H. De Greve, J. (2010) 2010 ASCO Annual Meeting — (USA- Chicago - Illinois
    • Speech
    Fulvestrant in heavily pretreated patients with advanced breast cancer: A Belgium cooperative study.
    Neven, Patrick[UCL] Paridaens, Robert[UCL] Pelgrims, G. Martens, M. Bols, A. Goeminne, J. C. Vindevoghel, A. Demol, J. Stragier, B. De Greve, J. Schallier, D. Van Den Weyngaert, D. Becquart, D. Borms, M. Cocquyt, V. Van Den Broecke, R. Selleslags, J. Awada, A. Dirix, L. Van Dam, P. Azerad, M. A. Vandenhoven, G. Christianes, M. R. Vergote, Antoine[UCL] (2006) 29th Annual San Antonio Breast Cancer Symposium — San Antonio(Tx)
    • Speech
    Multicenter parallel phase II trials of the polo-like kinase 1 inhibitor BI-2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. : The first protocol of the European Organisation for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)
    Schöffski, Patrick Blay, J. Y. De Greve, J. Brain, E. Machiels, Jean-Pascal[UCL] Soria, S. C. Sleijfer, S. Munzert, G. Rapion, J. Lacombe, D. (2009) 15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology — Berlin(Germany)